|星空彩票电脑版
%A LIU Zhi-jun %T
Epidemiology and Pharmacotherapy of Adult Attention Deficit/Hyperactivity Disorde: Current Status%0 Journal Article %D 2012 %J ACTA NEUROPHARMACOLOGICA %R %P 31-39 %V 2 %N 5 %U {http://actanp.hebeinu.edu.cn/CN/abstract/article_129.shtml} %8 2012-10-26 %X Attention deficit/hyperactivity disorder (ADHD) is the most frequently diagnosed neuro-developmental disorder
in children and most of the children ADHD cases can persist to adulthood. The DSM-5 developed and published by American Psychiatric Association (APA) at 2012 firstly gives the more appropriate diagnosis criteria and pharmacotherapy guidelines for adult ADHD. The currently used medications include neural
stimulants (e.g. methylphenidate and amphetamines) and non-stimulants (e.g. atomoxetine, buproprion and tricyclic antidepressants). Other medications such as venlafaxine, reboxetine, modafinil, oxcarbazepine and propranolol are also tested to treat adult ADHD and showed some therapeutic effects.